Aisling Capital — Full Portfolio

Lensar designs and markets laser systems for cataract surgery and corneal astigmatism correction, offering products that incorporate imaging and precision-guidance technologies to help surgeons achieve consistent visual outcomes.

HealthtechOrlando, US

Randy W Frey(Director)ABAlan B Connaughton(Executive Officer)inAmy R Brooks(Executive Officer)Peter J Mariani(Executive Officer)Keith H Edwards(Executive Officer)Ronald D Goldrich(Executive Officer)

Board seatSESteven ElmsJBJosh Bilenker· per SEC Form D

Co-investorsVEVersant Venture AIV Holdings

Marker Therapeutics develops novel T cell therapies, including adoptive T cell therapy approaches, for clinical applications in oncology and other diseases with high unmet need.

BiotechHealthtechHouston, US

JVJuan Vera(Executive Officer, Director)inDr. Vera(Co-founder)Glynn Wilson(Executive Officer, Director)John Bonfiglio(Executive Officer, Director)

BoardJohn Wilson(Director)

Board seatSESteven Elms· per SEC Form D

Co-investorsNENew Enterprise Associates (NEA)

Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases.

BiotechHealthtechMedical DevicesWayne, US

Neal Walker(Executive Officer, Director)Kamil Ali-Jackson(Executive Officer)SDStuart D. Shanler(Executive Officer)inJoseph Monahan(Executive Officer)inHDHugh Davis(Executive Officer, Director)inJames Loerop(Executive Officer)

Co-investorsAPAPERTURE Venture PartnersF-F-Prime CapitalFOForesite CapitalRARA CapitalSOSofinnova VenturesSOSofinnova Venture Partners+1 more

ADMA Biologics is a vertically integrated manufacturer that develops and commercializes plasma-derived biologic therapies for immune-compromised patients, and operates plasma collection centers.

Advanced ManufacturingBiotechHealthtechMedical DevicesHackensack, US

ASAdam S. Grossman(Executive Officer, Director)inJerrold B. Grossman(Co-founder & Vice Chairman)KKKaitlin Kestenberg(Chief Operating Officer & Senior Vice President of Compliance)inTKTerry Kohler(Chief Financial Officer & Treasurer)inPTPaul Terence Kohler, Jr.(Chief Financial Officer and Treasurer)BLBrad L. Tade(Chief Financial Officer and Treasurer (retiring))in

Spyre Therapeutics develops monoclonal antibodies with extended half-lives targeting inflammatory bowel disease and rheumatic conditions including rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis.

BiotechAustin, US

David G. Lowe(Executive Officer, Director)George Georgiou(Director)CNCharles N. York(Executive Officer)inCameron Turtle(Chief Executive Officer and Director)

BoardHenry Skinner(Director)Armen Shanafelt(Director)

Co-investorsRARA Capital

Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional antibody therapies that combine tumor-targeting with immune-modulating payloads to treat solid tumors.

IHIvan Hyep(Chief Financial Officer and Treasurer)inLara Meisner(Chief Legal Officer, Compliance Officer and Corporate Secretary)inDRDavid Raben(Chief Medical Officer)in

Co-investorsEIEight Roads VenturesF-F-Prime CapitalFOForesite CapitalPRPremji InvestRARA CapitalRERed Tree Venture+6 more

Biomea Fusion is a clinical-stage company developing oral small-molecule drugs for diabetes, obesity, and metabolic diseases, with lead programs including icovamenib, a menin inhibitor, and BMF-650, a GLP-1 receptor agonist.

BiotechRedwood City, US

TBThomas Butler(Executive Officer, Director)inRamses Erdtmann(Director, Executive Officer)inMichael J.M. Hitchcock(Interim Chief Executive Officer and Director)Rainer (Ramses) Erdtmann(Chief Operating Officer, President and Director)in

CalciMedica is a clinical-stage biopharmaceutical company developing CRAC (calcium release-activated calcium) channel inhibition therapies for serious acute and chronic inflammatory, immunologic, and cardiopulmonary diseases.

BiotechHealthtechLa Jolla, US

KAKenneth A. Stauderman(Co-founder)inGonul Velicelebi(Co-founder)Daniel Geffken(Executive Officer)A. Rachel Leheny(Executive Officer, Director)MJMichael J. Dunn(Executive Officer)inSBStephen Bardin(Chief Financial Officer)in

Co-investorsMEMESA VERDE VENTURE PARTNERSRERevelation PartnersSASanderling VenturesCLClarus VenturesOROrbiMed

Compass Pathways develops novel treatments for mental health conditions, with a focus on psychedelic-assisted therapies supported by rigorous clinical research.

BiotechDigital HealthHealthtechMedical DevicesMental Health

Kabir Nath(CEO)Ekaterina Malievskaia(Founder)George Goldsmith(Founder)

Co-investorsABAble PartnersBABailey Venture PartnersCACatalio Capital Management, LPNONoeticOMOMX VenturesVIVivo Capital+2 more

Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases.

BiotechHealthtechMedical DevicesNorthbrook, US

JAJeffrey Aronin(Director)inJMJeffrey M. Dayno, M.D.(President and Chief Executive Officer)inPatrick Morris(Secretary and Treasurer)inRobert Repella(Director and Chief Executive Officer)Darien Parhad(Chief Financial Officer)

BoardARAaron Royston(Director)in

Co-investorsHBHBM Healthcare InvestmentsHBHBM PartnersPAParagon Biosciences LLCPIPivotal Life SciencesVAValor Equity PartnersVEvenBio Partners+3 more

Johnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision.

BiotechHealthtechMedical DevicesNew Brunswick, US

EMEdward Mead JohnsonJWJames Wood JohnsonRWRobert Wood Johnson IJDJoaquin DuatoinJ. Duato(Chief Executive Officer)

Co-investorsATAtlas VentureNANaviMed CapitalPOPortland Seed FundSPSPRINGROCK VENTURESTHThe Column GroupVEvenBio Partners

Nuvation Bio is a global oncology company that develops novel cancer therapies through its own drug discovery programs and business development, serving cancer patients.

BiotechHealthtechNew York, US

DHDavid Hung(Founder)inDavid Hanley(Chief Technical Operations Officer)inGHGary Hattersley(Chief Scientific Officer)inSMStacy Markel(Chief People Officer)inPSPhilippe Sauvage(Chief Financial Officer)inCSColleen Sjogren(Chief Commercial Officer)in

Co-investorsDEDecheng CapitalECEcoR1 CapitalVEVertex Ventures ChinaOMOmega Funds

Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.

BiotechHealthtechMilpitas, US

Dinesh V. Patel, PhD(Executive Officer, Director)DPDinesh Patel(President & Chief Executive Officer)

BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)Paul F. Truex(Director)

Co-investorsCACanaan PartnersJJJJDCJOJohnson & Johnson Innovation – JJDCLILilly VenturesRARA CapitalSTStarfish Ventures

Scholar Rock is a biopharmaceutical company that develops therapies targeting growth factor proteins to treat serious diseases.

BiotechCambridge, US

NMNagesh Mahanthappa(Executive Officer, Director)inTSTimothy Springer(Director)David Hallal(Chief Executive Officer, Chairman and Director)inAVAkshay Vaishnaw(President of Research & Development and Director)inR. Keith Woods(Chief Operating Officer)inVSVikas Sinha(Chief Financial Officer)in

Co-investorsARARCH Venture PartnersECEcoR1 CapitalPOPolaris PartnersTHThe Kraft Group

Spruce Biosciences develops and commercializes therapies for serious neurological and endocrine disorders with unmet medical need, with a lead investigational enzyme replacement therapy (TA-ERT) for Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome Type B).

BiotechHealthtechSouth San Francisco, US

SGSamir Gharib(Executive Officer)inRICHARD KING(Executive Officer, Director)inJSJavier Szwarcberg(Chief Executive Officer)in

BoardSimpson Camilla(Director)TATiba Aynechi(Director)inBMBali Muralidhar(Director)in

Co-investorsHEHealthCapRIRiverVest Venture PartnersABAbingworthNONorwest Venture PartnersNONovo HoldingsOMOmega Funds+1 more

Spyre develops and commercializes treatments for a broad range of diseases focused on improving patient outcomes.

BiotechHealthtechMedical Devices

CTCameron Turtle(Chief Executive Officer and Director)in

Co-investorsACAccess Biotechnology

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company that develops and commercializes small-molecule and antibody cancer therapies, including two FDA-approved medicines: revumenib (a menin inhibitor for acute leukemias) and axatilimab (a CSF-1R blocking antibody for graft-versus-host disease and fibrotic diseases), along with clinical-stage programs exploring expanded uses and combinations in oncology.

BiotechWaltham, US

John Pallies(Executive Officer)inAMArlene Morris(Executive Officer, Director)inMAMichael A. Metzger(Chief Executive Officer)inKAKeith A. Goldan(Chief Financial Officer)in

BoardDPDennis Podlesak(Director)inIvor Royston(Director)

Co-investorsATATEM Capital FundAVAvoro Capital AdvisorsBIBioBritDEDelos CapitalECEcoR1 CapitalFOForesite Capital+6 more

Earlens makes a hearing aid that vibrates the eardrum directly rather than using speakers to amplify sound, allowing amplification across a broad audible frequency range including higher frequencies for speech understanding.

HardwareHealthtechMedical DevicesMenlo Park, US

Rodney Perkins, M.D.(Director)William M. Facteau(Executive Officer, Director)Bernard Shay(Executive Officer)Phil Lyons(Executive Officer)BEBrent Edwards(Executive Officer)Greg Koskowich(Executive Officer)

Board seatSESteven Elms· per SEC Form D

Co-investorsNENew Enterprise Associates (NEA)WIWindham Capital PartnersLILightstone VenturesMOMorgenthalerSISightLine Partners

A digital health resource platform providing medical professionals with educational information and clinical resources about transthyretin amyloid cardiomyopathy (ATTR-CM) and related cardiac and neurological conditions.

BiotechDigital HealthHealthtechSan Francisco, US

NKNEIL KUMAR(Executive Officer, Director)JONATHAN FOX(Executive Officer)UMA SINHA(Executive Officer)CHRISTINE SIU(Executive Officer)HOYOUNG HUH(Director)ERIC AGUIAR(Director)

Board seatEAEric Aguiar· per SEC Form D

Co-investorsFOForesite CapitalRARA CapitalVIViking GlobalVIViking Global Investors

BiotechCambridge, US

Dhvanit I Shah(Chief Executive Officer of the Issuer)David Kirske(Executive Officer)Adam Craig(Executive Officer, Director)

BoardGeoff Meyerson(Director)Raymond Kelleher(Director)

Board seatEAEric Aguiar· per SEC Form D

Invitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life.

BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

SGSean George(Executive Officer, Director)inRandal Scott(Executive Officer, Director)SGShelly Guyer(Executive Officer)inLBLee Bendekgey(Executive Officer)inGeoffrey Crouse(Director)

Board seatEAEric Aguiar· per SEC Form D

Co-investorsCICivilization Ventures Management, LlcDEDecheng CapitalFIFifty YearsMAManta Ray VenturesOBOberland CapitalPRPrefix Capital+4 more

Summus Global provides doctor-led clinical navigation and virtual access to specialists across 120+ medical specialties, offering members personalized guidance, second opinions, in-network recommendations, and condition-specific support programs.

Digital HealthHealthtechWellness & FitnessNew York, US

JFJulian Flannery(Executive Officer, Director)in

BoardRick Buhrman(Director)DPDennis Purcell(Executive Officer)inAKAftab Kherani(Director)Scott Harrison(Director)

Board seatAyman Sabi· per SEC Form D · $16M raise · filed Apr 2021

Co-investorsOUOutsidersTETeamworthy Ventures

Asensus Surgical (formerly TransEnterix) develops robotic-assisted surgical systems and augmented intelligence technology, including reusable instruments, to give surgeons real-time information during procedures.

AI & Machine LearningHealthtechMedical DevicesRoboticsMorrisville, US

AFAnthony Fernando(Executive Officer)inTodd M. Pope(Executive Officer, Director)inJoseph P Slattery(Executive Officer)inJames J. Martin(Executive Officer)Charles J. Filipi(Executive Officer, Director)Jeffrey G. Spragens(Executive Officer, Director)

Board seatAKAftab Kherani· per SEC Form D

Co-investorsSASaints CapitalSVSV Health InvestorsQUQuaker BioVenturesSVSV Life Sciences

Treeline develops therapeutics focused on oncology, leveraging insights from clinical practice and laboratory research.

AI & Machine LearningBiotechHealthtechMedical DevicesWatertown, US

JHJoshua H. Bilenker(Executive Officer, Director, Promoter)Jeffrey Engelman(Executive Officer, Director, Promoter)inJosh Bilenker(Founder)inJosh Bilenker Jeff Engelman(Founder)

BoardKBKristina Burow(Director)inAli Satvat(Director)

Board seatSESteven ElmsAKAftab Kherani· per SEC Form D

Co-investorsARARCH Venture PartnersGVGV (Google Ventures)OROrbiMedARARC VENTURESCACasdin CapitalEXExor+3 more

Advion Interchim Scientific provides laboratory instruments, consumables, reagents, and software for chemical analysis and purification tasks such as chromatography, mass spectrometry, and ICP-MS.

BiotechDeep TechEnterprise SoftwareHardwareHealthtechMedical DevicesIthaca, US

John D. Henion(Director)JJJamey Jones(Chief Executive Officer)inDBDavid B. Patteson(Executive Officer, Director)inJoseph M. Kiely(Executive Officer)WXWayne Xiong(CFO & Interim CEO/DG)

BoardJohn G. Freund(Director)

Co-investorsGEGefinor Capital

Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusion® transdermal technology platform.

BiotechFemTechHealthtechPrinceton, US

KMKatie MacFarlane(Executive Officer)inScott M. Coiante(Executive Officer)AAAl Altomari(Executive Officer, Director)inEGElizabeth Garner(Executive Officer)in

BoardKaren Hong(Director)inAbhijeet Lele(Director)

Co-investorsKAKaiser Permanente VenturesDEDe Novo Ventures

Aimmune Therapeutics developed desensitization treatments for life-threatening food allergies, including Palforzia, the first FDA-approved peanut allergy treatment.

Co-investorsFOForesite CapitalLOLongitude CapitalMEMenlo Ventures

Ajax Health is a life science investment firm that manages a portfolio of medtech, biopharma, and diagnostic companies.

BiotechHealthtechMedical DevicesNew York, US

BoardAftab(Managing Partner)

Co-investorsWEWestern Technology Investment

Ambit Biosciences was a San Diego biopharmaceutical company developing small-molecule kinase inhibitors, including quizartinib, a FLT3 inhibitor for acute myeloid leukemia.

Co-investorsFOForesite Capital

Pfizer discovers, develops, manufactures, and distributes pharmaceutical medicines and vaccines across therapeutic areas including oncology, cardiology, immunology, and infectious diseases.

BiotechHealthtechMedical DevicesNew York, US

Charles Pfizer

Co-investorsANAndera PartnersRHRho Capital PartnersRHRho VenturesRIRiverVest Venture PartnersVEVenrockNENew Enterprise Associates (NEA)

Antios Therapeutics develops antiviral therapies for hepatitis B virus (HBV) and other viral diseases, including its Active Site Polymerase Inhibitor Nucleotide (ASPIN) ATI-2173 and a capsid assembly modulator program.

BiotechHealthtechMendham, US

Gregory Mayes(Executive Officer, Director)DMDouglas Mayers(Executive Officer)inTATamra Adams(Executive Officer)inAbel De La Rosa(Director)

BoardIRIyona Rajkomar(Director)inBenjamin Rovinski(Director)

Co-investorsALAltium CapitalAVAvego BioScience CapitalLILifeSci Venture PartnersPOPontifax Venture CapitalAMAmzak HealthDEDelos Capital+8 more

Arcus Biosciences is a clinical-stage biopharmaceutical company that designs small molecule and monoclonal antibody combination therapies for people with cancer.

BiotechHealthtech

Juan Jaen(Co-founder & President)inTerry Rosen(Co-founder & Chief Executive Officer)inBob Goeltz(Chief Financial Officer)inRMRichard Markus(Chief Medical Officer)inCTCarolyn Tang(General Counsel)Yvonne Gehring(SVP, Human Resources)

Co-investorsDEDecheng CapitalDRDroia VenturesECEcoR1 CapitalFOForesite CapitalGVGV (Google Ventures)SLSLVC+4 more

B-FLEXION is an investment group with a heritage in biopharmaceuticals spanning three generations, operating asset managers across multiple investment areas and holding stakes in transformative operating businesses.

BiotechSector Agnostic

ARMGO develops a novel class of therapeutics called Rycals that target ryanodine receptors (RyRs) to correct calcium channel dysfunction in serious diseases with high unmet need.

BiotechDeep TechHealthtech

Ascendis Pharma is a biopharmaceutical company developing therapies for hormone-related disorders and rare diseases.

BiotechHealthtechMedical DevicesDenmark, DK

JMJan Møller Mikkelsen(Founder, President and Chief Executive Officer)inGrethe Rasmussen(Executive Officer)inHarald Rau(Executive Officer)Martin Olin(Director)Lotte S?nderbjerg(Executive Officer)MAMartin Auster(Executive Officer)in

Co-investorsVIVivo CapitalAVAvoro Capital AdvisorsFOForesite CapitalRARA CapitalSOSofinnova PartnersSOSofinnova Ventures

BiotechRedwood City, US

William Robinson(Director)LSLawrence Steinman(Director)TSTito Serafini(Executive Officer, Director)

BoardBrian Atwood(Director)Franklin Berger(Director)

Co-investorsECEcoR1 CapitalEVEvolution VC PartnersMIMission Bay CapitalMIMission Biocapital

Biohaven is a biopharmaceutical company that discovers, develops, and commercializes treatments across immunology, obesity, neuroscience, and oncology, targeting rare and common diseases with limited treatment options.

BiotechHealthtech

VCVlad Coric(Chairman & Chief Executive Officer)in

Co-investorsAPAPERTURE Venture PartnersCOConnecticut InnovationsOUOUP (Osage University Partners)HBHBM Healthcare InvestmentsOROrbiMed

Biopharmaceutical developer of tumor-selective PARP inhibitor cancer therapies, acquired by Sanofi-aventis in 2009.

Co-investorsASAsset Management CompanyCACanaan PartnersKLKleiner PerkinsSPSPRINGROCK VENTURESVAVantagePoint Capital PartnersDODomain Associates

BridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support.

BiotechHealthtech

Neil Kumar(Founder)

Co-investorsAMAmzak HealthECEcoR1 CapitalFRFrazier Life SciencesHEHEALTHCARE ROYALTY PARTNERSLOLongwood FundSESequoia Capital+2 more

BridgeBio Oncology develops cancer therapies targeting tumors driven by RAS and PI3Kα signaling, using RAS signaling biology to design drugs that inhibit RAS-driven PI3K activation and a range of KRAS mutants in both their active (ON) and inactive (OFF) states.

BiotechHealthtech

Co-investorsWEWellington Management

Catalent is a global Contract Development and Manufacturing Organization (CDMO) that helps pharma, biotech, and self-care companies develop, manufacture, and deliver drug products and consumer health solutions.

Advanced ManufacturingBiotechHealthtechSomerset, US

JRJohn R. Chiminski(Executive Officer, Director)inWJWetteny Joseph(Executive Officer)inDonald E. Morel Jr.(Director)Peter Zippelius(Director)

BoardJack L. Stahl(Director)Madhavan Balachandran(Director)

Co-investorsHAHavencrest Capital ManagementLELeonard GreenBLBlackstone

Chiesi is a global pharmaceutical company that develops and distributes medications across multiple therapeutic areas.

BiotechHealthtechMedical DevicesParma, US

Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.

BiotechHealthtechMedical DevicesDurham, US

Mike Sherman(Chief Executive Officer and President)W. Garrett Nichols(Chief Medical Officer)Michael A. Alrutz(Executive Officer)Randall Lanier(Chief Science Officer)Roy W. Ware(Chief Manufacturing and Technology Officer)Heather Knight-Trent(Vice President of Regulatory Affairs)

Co-investorsALAlta PartnersASAsset Management CompanyCACanaan PartnersFRFrazier Life SciencesPAPappas CapitalSASanderling Ventures

Pharmaceutical company developing medicines and vaccines for patient health and treatment.

BiotechHealthtechSan Diego, US

JSJeffrey Stein(Executive Officer, Director)KJKevin Judice(Director)inKevin Forrest(Executive Officer)DTDirk Thye(Executive Officer)inKen Bartizal(Executive Officer)inPDPaul Daruwala(Executive Officer)in

Co-investors5A5AM VenturesBABain Capital Life SciencesFRFrazier Life SciencesRARA CapitalVIVivo CapitalCACanaan Partners+1 more

Developed targeted cancer therapies with companion diagnostics (Rubraca); IPO'd in 2011 (NASDAQ: CLVS).

Patrick Mahaffy(Founder)in

Co-investorsFRFrazier Life SciencesNENew Enterprise Associates (NEA)PFPfizer Venture InvestmentsRIRidgeback Capital

Colorescience is a professional skincare brand that develops mineral-based sun protection (SPF), skincare, and color correction products, originally created for post-procedure skin and marketed for all ages and skin types.

ConsumerDirect to ConsumerHealthtechWellness & FitnessCarlsbad, US

Stephen Loomis(Executive Officer)MFMary Fisher(Executive Officer, Director)inTheodore Ebel(Executive Officer)Josie Juncal-Schwarz(Executive Officer)

BoardM Bolyard(Director)Brian Dovey(Director)in

Co-investors131315 CapitalRERevelation PartnersRORoundTable Healthcare PartnersDODomain AssociatesHEHealthCare Ventures, LLCLOLongwood Fund+2 more

CoolSculpting offers FDA-cleared body-contouring procedures that use controlled cooling to reduce visible fat bulges in areas such as the chin, abdomen, thighs, and flanks, along with the CoolTone device for muscle strengthening and toning.

HealthtechMedical DevicesWellness & Fitness

Co-investorsLILightstone Ventures

Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries.

BiotechDigital HealthHealthtechMedical DevicesFoster City, US

LLLou Lange(Founder)MLMichael L. Riordan(Founder)inDODaniel O'Dayin

Co-investorsASAsset Management CompanyFRFrazier Life SciencesKLKleiner PerkinsLOLongitude CapitalLULumira VenturesMEMenlo Ventures+6 more

IQVIA (via the quintiles.com domain) provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution.

AI & Machine LearningBiotechHealthtech

Co-investorsACAccess Venture Partners

Cynapsus is a specialty central nervous system pharmaceutical company developing a fast-acting sublingual thin film for on-demand management of OFF episodes in Parkinson's disease patients.

BiotechDigital HealthHealthtechMedical DevicesToronto, CA

Anthony Giovinazzo(Executive Officer, Director)AWAndrew Williams(Executive Officer)TBThierry Bilbault(Executive Officer)Nathan Bryson(Executive Officer)

BoardIlan Oren(Director)Tomer Gold(Director)

Cytos is an orthobiologics company that develops biologic treatments for orthopedic conditions.

BiotechHealthtechMedical Devices

Co-investorsHEHealthCap

HealthtechMenlo Park, US

Thomas G. Wiggans(Executive Officer, Director)inEugene A. Bauer(Executive Officer, Director)Andrew Guggenhime(Executive Officer)Luis Pena(Executive Officer)Christopher Griffith(Executive Officer)

BoardFCFred Craves(Director)in

Co-investorsBABay City CapitalCACanaan PartnersFOForesite CapitalNENew Enterprise Associates (NEA)FIFidelity InvestmentsQIQiming Healthcare+1 more

Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.

BiotechHealthtechMedical DevicesFoster City, US

NTNenad Tomasevic(Founder)

BoardIvan Trifunovich(Director)John Wesley(Founder)

Co-investors8V8VCHBHBM Healthcare InvestmentsHBHBM PartnersJAJacket River Capital PartnersMIMission Bay CapitalMIMission Biocapital+5 more

Biopharma developing HDL-C regulating therapies; listed 2000.

BiotechAnn Arbor, US

Roger S. Newton(Director)inTim M. Mayleben(Executive Officer, Director)

BoardDaniel Janney(Director)Dov A. Goldstein(Director)NVNicole Vitullo(Director)inPEPatrick Enright(Director)in

Co-investorsALAlta PartnersARArboretum VenturesARARCHIMED JapanASAsset Management CompanyCACanaan PartnersHEHealthCap+5 more

Archimica is a contract manufacturer of active pharmaceutical ingredients (APIs), GMP building blocks and reagents, offering process development and production from clinical to large commercial scale for innovative and generic pharmaceutical companies.

Advanced ManufacturingBiotechHealthtechLodi, IT

F2G develops medicines to treat serious fungal diseases where existing therapies have failed or are ineffective.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsADAdvent Life SciencesAMAMR Action FundASAstellas Venture Management LLCBRBrace PharmaSOSofinnova PartnersSUSunstone Capital+4 more

Forge Biologics is a US-based gene therapy CDMO (contract development and manufacturing organization) offering AAV manufacturing services, technologies, and infrastructure.

Advanced ManufacturingBiotechHealthtechMedical DevicesGrove City, US

TJTimothy J. Miller(Executive Officer, Director)in

BoardChris Garabedian(Director)inMMMolly McCartin(Director)in

Co-investorsDRDrive CapitalRARA Capital

Galderma is a dermatology-focused company that develops and delivers branded pharmaceutical and medical solutions across the full spectrum of skin care and dermatological treatments.

BiotechConsumerHealthtechMedical Devices

Flemming Ørnskov(Chief Executive Officer)

Co-investorsARArdian

Global Blood Therapeutics was a South San Francisco biopharmaceutical company founded in 2011 focused on treatments for sickle cell disease.

South San Francisco, US

JSJohn Schembri(Executive Officer)inTed W. Love(Executive Officer, Director)in

BoardKSKevin Starr(Director)inCharles Homcy, M.D.(Director)

Co-investorsAVAvoro Capital AdvisorsRARA CapitalRIRidgeback CapitalTHThird Rock VenturesWEWellington Management

GondolaBio is a clinical-stage biopharmaceutical company developing therapeutics for patients with genetic diseases, with a lead oral small-molecule program (PORT-77) targeting erythropoietic protoporphyria and X-linked protoporphyria.

BiotechHealthtech

Co-investorsFRFrazier Life SciencesPAPatient Square CapitalVIViking Global

IMBRUVICA is a prescription cancer medication (available as capsules, tablets, and oral suspension) used to treat B-cell malignancies such as CLL/SLL and Waldenström's macroglobulinemia, as well as chronic graft-versus-host disease in adults and children.

BiotechHealthtech

Immunotherapy oncology company engineering technologies to activate the immune system; acquired by Merck in February 2019 for $0.3B.

BiotechHealthtechMedical DevicesSeattle, US

DBDavid Baltimore(Director)Carlos V. Paya(Executive Officer, Director)Stephen R. Brady(Executive Officer)inJHJan Henrik ter Meulen(Executive Officer)Paul Rickey(Executive Officer)inWayne Gombotz(Executive Officer)in

Co-investorsATAtlas VentureHMHM Venture PartnersOUOUP (Osage University Partners)SASanderling VenturesSASanofi VenturesSPSPRINGROCK VENTURES+4 more

Intercept Pharmaceuticals develops and commercializes treatments for rare and serious liver and other diseases, with a focus on conditions such as primary biliary cholangitis.

BiotechHealthtechMedical Devices

Co-investorsBIBioBritRIRidgeback CapitalSASamsara BioCapital

Aesthetic-medicine biopharma behind KYBELLA (deoxycholic acid) injection, acquired by Allergan in 2015 for ~$2.1 billion.

Allen Chao(Founder)

Co-investorsARARCH Venture PartnersMEMESA VERDE VENTURE PARTNERSPRProspect Venture PartnersSCSchooner CapitalALALTITUDE LIFE SCIENCE VENTURESFOFoley Ventures+2 more

LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.

AI & Machine LearningBiotechDeep TechCambridge, US

GLGregory L. Verdine(Executive Officer, Director)GVGregory Verdine, Ph.D.

BoardHingge Hsu(Executive Officer, Director)Weiqing Zhou(Executive Officer, Director)

Co-investorsARARCH Venture PartnersGVGV (Google Ventures)RARA CapitalALAlexandriaBEBezos ExpeditionsBLBlue Pool Capital+7 more

Minos is an abdominal aortic stent graft device designed for endovascular aneurysm repair, featuring a tri-modular design with ultra-low profile delivery and helical stent limbs for deployment in aortic and iliac anatomy.

HardwareHealthtechMedical Devices

Co-investorsCACamden Partners

Loxo develops SAE Level 4 autonomous driving technology, marketed as a vehicle-agnostic "Digital Driver" for urban delivery operations.

AI & Machine LearningLogistics & Supply ChainMobility & Transportation

Co-investorsSESerpentine VenturesOROrbiMed

BiotechStamford, US

JHJoshua H. Bilenker(Executive Officer, Director)

BoardDov Goldstein(Director)James Barrett(Director)David Bonita(Director)SESteven Elms(Director)inAvi Naider(Director)

Co-investorsNENew Enterprise Associates (NEA)OROrbiMed

Lite Strategy, Inc.

BiotechCrypto & Web3FintechHealthtechSan Diego, US

DMDavid M. Urso(Executive Officer)inDaniel P. Gold(Executive Officer, Director)BGBrian G. Drazba(Executive Officer)inMr. File(Chief Executive Officer & Board Member (former CFO))J(Justin (Jay) File(CEO, CFO)inKevan E. Clemens(Director)

Co-investors3B3B Future Health FundGSGSRNENew Enterprise Associates (NEA)PRPrimitive VenturesAMAmzak HealthBIBiotechnology Value Fund+1 more

Mindful Health Solutions is a provider of behavioral health care specializing in advanced psychiatric treatments including Transcranial Magnetic Stimulation (TMS), esketamine nasal spray, IV ketamine therapy, and emerging psychedelic therapies, primarily for treatment-resistant depression.

Digital HealthHealthtechMedical DevicesMental Health

Co-investorsNONorwest Venture Partners

miraDry provides a non-invasive medical treatment aimed at improving patients' physical and emotional wellbeing, marketed to clinical customers and patients.

HealthtechMedical DevicesWellness & Fitness

Co-investors131315 CapitalCRCross Creek Advisors

Medical Knowledge Group (MKG) is a commercialization partner for biopharma companies, offering data solutions, therapeutic expertise, and strategic advisory across a brand's product lifecycle.

Data & InfrastructureHealthtechMarketing Tech

BiotechDublin 1

Jennifer Schranz(Executive Officer)Axel Bolte(Director)Gary Sender(Executive Officer)Theodore Schroeder(Executive Officer, Director)Robert Crotty(Executive Officer)Colin Broom(Director)

Co-investorsECEcoR1 CapitalFRFrazier Life SciencesLOLongitude CapitalMEMESA VERDE VENTURE PARTNERSNONovartis Venture Fund

The page is a Vietnamese-language sports streaming site (90Phut TV / 90Phutr.tv, also called Vaoroi TV) offering free live football streaming links, match schedules, standings, results, news, and betting odds.

Media & EntertainmentSports TechHà Nội, VN

Co-investorsM M VenturesNENew Enterprise Associates (NEA)SOSofinnova PartnersSOSofinnova Ventures

Paratek Pharma develops and commercializes specialty therapies for patients with life-threatening infectious diseases and difficult-to-treat conditions.

BiotechDigital HealthHealthtechMedical DevicesBoston, US

Evan Loh(Executive Officer, Director)Sean M. Johnston(Executive Officer)inBeverly Armstrong(Executive Officer)Dennis Molnar(Executive Officer)inKathryn Boxmeyer(Executive Officer)inS. Ken Tanaka(Executive Officer)

BiotechMenlo Park, US

Ervin Epstein(Executive Officer, Director)inJean Tang(Director)Mark de Souza(Executive Officer)

BoardKatrin Andreasson(Director)

Co-investorsECEcoR1 Capital

Pharmaron is a contract research and manufacturing organization providing drug development and manufacturing services to pharmaceutical and biotech companies.

BiotechDeep TechHealthtechMedical DevicesBeijing, CN

Boliang Lou(Chairman & CEO)in

Co-investorsDCDCM VenturesSCScientia VenturesDCDCMLELegend Capital

Irvine, US

Sanjay Rajpoot(Executive Officer, Director)

Poseida Therapeutics develops cell therapy candidates and related platform technologies for healthcare applications.

BiotechHealthtechSan Diego, US

EOEric Ostertag(Executive Officer, Director)MGMark Gergen(Executive Officer, Director)

BoardAdrian Howd(Director)David Hirsch(Director)

Co-investorsLOLongitude CapitalRARapha Capital Management, LLCVIVivo Capital

HealthtechBelmont, US

Barry Cheskin(Executive Officer, Director)S. Arieh Zak(Executive Officer)George Green(Executive Officer)

BoardDrew Schiff(Director)Michael Carusi(Director)Lou Bock(Director)

Co-investorsARArcher Capital GroupARArcher Venture CapitalLILightstone VenturesFRFrazier Life SciencesJOJohnson & Johnson Innovation – JJDCSCScale Venture Partners

Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units.

BiotechHealthtechMedical DevicesCity Of Industry, US

SEScott Elster(Executive Officer, Director)inJMJohn M. Shields(Executive Officer)in

BoardFFFrank Foster(Director)MSMartin Sutter(Director)David Brailer(Director)Dan Janney(Director)

Co-investorsESEssex Woodlands Healthcare PartnersFRFrontier Venture CapitalPRPROOFALAlta Partners

Promentis Pharmaceuticals is a privately-held biopharmaceutical company developing oral compounds targeting the System xc- glutamate pathway to treat neuropsychiatric disorders.

BiotechHealthtechMental HealthMilwaukee, US

DBDavid Baker, PhD(Director)DLDaniel Lawton(Executive Officer, Director)TBTom Beck(Executive Officer, Director)Chad Beyer(Executive Officer)Chad E Beyer, PhD(Executive Officer, Director)

BoardKVKlaus Veitinger(Executive Officer, Director)in

Co-investorsF-F-Prime CapitalOROrbiMed

Reckitt is a global health and hygiene company that manufactures and sells trusted consumer brands for personal care, home care, and health solutions.

ConsumerHealthtechWellness & Fitness

Reneo is an asset and investment management platform for decarbonizing residential real estate portfolios in Germany.

Climate TechEnterprise SoftwarePropTechGermany, DE

LBLennart Börner(Founder & Co-CEO)inAGAlexander Graubner-Müller(Founder & Co-CEO)in

Co-investorsFOFoundamentalABAbingworthAMAmzak HealthEUEurazeoLALakestarLULundbeckfonden Ventures+4 more

Xoilac TV is a free online football (soccer) live-streaming platform serving fans in Vietnam, offering Full HD match broadcasts of European, Asian, Vietnamese, and international competitions.

ConsumerMedia & EntertainmentSports Tech

Co-investorsNENew Enterprise Associates (NEA)PAPappas CapitalRIRiverVest Venture PartnersABAbingworthAMAmzak HealthLULundbeckfonden Ventures+2 more

Roka Bioscience develops molecular testing assays and automated instrument systems for rapid pathogen detection in food manufacturing.

BiotechFoodTechHealthtechMedical DevicesWarren, US

LBLars Boesgaard(Executive Officer)Paul G. Thomas(Executive Officer, Director)

BoardJim Barret, PhD(Director)Fred Cohen(Director)Jonathan Silverstein(Director)David McGirr(Director)

Sorrento Therapeutics is a biotechnology and life sciences company that develops therapeutics and technologies through in-house programs, acquisitions, and mergers.

BiotechDeep TechLongevity

HJHenry Ji(Chairman, President and CEO)Scott Schaus(Chief Technology Officer)

Co-investorsCACanaan PartnersFRFrazier Life Sciences

Genentech is a biotechnology company that develops and manufactures breakthrough medicines in the United States, backed by a $50 billion commitment to U.S. manufacturing and scientific innovation.

AI & Machine LearningBiotechDigital HealthSouth San Francisco, US

Co-investorsKLKleiner PerkinsNENew Enterprise Associates (NEA)THThe Column Group

SkinMedica is a skincare company that develops and sells topical products for various skin concerns including cleansing, anti-aging, and skin repair.

BiotechConsumerDirect to ConsumerWellness & FitnessCarlsbad, US

Theodore Schwarz(Executive Officer)George Jenkins(Director)Andrew N. Schiff, M.D.(Director)Brian Dovey(Director)David F. Hale(Director)Theodore Ebel(Executive Officer)

Menlo Park, US

DRDuke Rohlen(Chief Executive Officer)

BoardCamille Samuels(Director)ANAnthony Natale(Director)inReed Gaither(Director)AKAftab Kherani(Director)Ron Kuppersmith(Director)

Co-investorsAPAPERTURE Venture PartnersCOCorrelation VenturesVEVenrockWEWestern Technology InvestmentHEHealthQuest Capital

Stiefel is a biopharmaceutical company that discovers, develops and delivers medicines and vaccines.

BiotechHealthtech

Developing off-the-shelf hematopoietic stem cell therapies for severe diseases.

Co-investorsOROrbiMedNONorthpond Ventures

Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.

BiotechCambridge, US

Nancy Simonian(CEO)Peter Wirth(Director)Mark Alles(Director)Philip Sharp(Director)Richard A. Young(Director)Sue Gail Eckhardt(Director)

Co-investorsARARCH Venture PartnersQUQuan CapitalALAlexandriaALAlly Bridge GroupBABain CapitalBABain Capital Life Sciences+11 more

HealthtechLexington, US

Michael Cima, Ph.D.(Director)RDRahul Dhanda(Senior Vice President, Corporate Development)inJMJohn McDonough(Chief Executive Officer)inTom Lowery, Ph.D.(Chief Scientific Officer)Michael Gibbs, Esq.(Vice President and General Counsel)Joanne Spadoro, Ph.D.(Chief Operating Officer)in

Co-investorsAPAPERTURE Venture PartnersINIn-Q-TelARArcus VenturesFLFlagship VenturesFLFlybridge Capital PartnersJOJohnson & Johnson Innovation – JJDC+2 more

Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions

BiotechLouisville, US

Suzanne Ildstad(Executive Officer, Director)SRScott Requadt(Executive Officer, Director)Geoff Mackay(Director)Francois Nader(Director)

BoardSASandip Agarwala(Director)inMMMark McDade(Director)in

Co-investorsKEKeyhorse CapitalLOLongitude CapitalQIQiming Venture Partners USAVIViking GlobalBLBlackstone Life SciencesCICitadel+3 more

Tria develops handheld laser devices for at-home hair removal and skincare, using laser technology similar to that used in professional clinics.

ConsumerDirect to ConsumerHardwareHealthtechWellness & FitnessDublin, US

TCTOBIN C. ISLAND(Executive Officer)inKJKEVIN J. APPELBAUM(Executive Officer, Director)inDYDEREK YUNG(Executive Officer)inDHDANIKA HARRISON(Executive Officer)inJIYOUNG CHOI(Executive Officer)CHARLES BRACHER(Director)in

Co-investorsBABay City CapitalINIncubic Management LLCVIVivo Capital

UroGen is a biotech company developing treatments for urothelial and specialty cancers using a proprietary sustained-release hydrogel platform technology.

BiotechHealthtechMedical DevicesPrinceton, US

Mark Schoenberg, M.D.(Executive Officer)LBLiz Barrett(President and Chief Executive Officer)inJason Smith(Executive Officer)Arie Belldegrun, M.D.(Director)Dan Wildman(Director)Don Kim(Executive Officer)

Co-investorsMOMonograph Capital PartnersPOPontifax Venture CapitalARAravis Ventures

Verona Pharma develops treatments for chronic lung conditions.

BiotechHealthtechLondon

Jan-Anders Karlsson(Executive Officer, Director)inPSPeter Spargo(Executive Officer)inPatrick Humphrey(Director)Ken Cunningham(Director)Kenneth Newman(Executive Officer)Anders Ullman(Director)

Co-investorsACAccess BiotechnologyANAndera PartnersFOForesite CapitalFRFrazier Life SciencesNENew Enterprise Associates (NEA)SOSofinnova Partners+4 more

ViewRay develops MRIdian A3i, an MRI-guided radiation therapy system that uses diagnostic-quality MRI imaging for real-time tissue tracking and automated beam control during cancer treatment.

HardwareHealthtechMedical DevicesOakwood Village, US

JFJames F. Dempsey(Executive Officer, Director)inDavid Chandler(Mr. Chandler is the Chief Financial Officer of the Issuer.)CAChris A. Raanes(Executive Officer, Director)Michael Brandt(Executive Officer)D. David Chandler(Executive Officer)Gregory M. Ayers(President and Chief Executive Officer of the Issuer.)

Co-investorsF-F-Prime CapitalXEXeraya CapitalOROrbiMed

Viracta Therapeutics was a precision oncology company.

BiotechHealthtechCardiff, US

James Woody(Director)David Slack(Executive Officer)

BoardIvor Royston(Executive Officer, Director)Patrick Soon-Shiong(Director)Richard Ghalie(Director)

Co-investorsLALatterell Venture PartnersAMaMoonVIVirtus Inspire Ventures

VIVUS is a pharmaceutical company developing and commercializing therapies for patients with serious medical conditions and life-limiting diseases.

BiotechHealthtechMedical Devices

JAJohn Amos(Chief Executive Officer)inSTSantosh T. Varghese(President VIVUS Global Pharmaceutical Development & Chief Medical Officer)in

Co-investorsFRFrazier Life Sciences

Allotera (formerly Wugen) develops allogeneic T-cell therapies.

BiotechHealthtechMedical DevicesSt. Louis, US

AKAyman Kabakibi(Executive Officer)inCherry Thomas(Executive Officer)inKSKumar Srinivasan(Executive Officer, Director)inKeith Vendola(Executive Officer)Daniel M Kemp(Executive Officer, Director)Matthew Cooper(Executive Officer)

Co-investorsALAlpha Wave GlobalBIBioGenerator VenturesRIRiverVest Venture PartnersABAbingworthFIFidelity InvestmentsINIntermediate Capital Group+1 more

BiotechFremont, US

Peter Daddona(Executive Officer, Director)inWinnie Tso(Executive Officer)inNandan Oza(Executive Officer)inVikram Lamba(Executive Officer, Director)inChristopher Krueger(Executive Officer)

BoardM. James Barrett(Director)